Article

Severe and multifaceted systemic immunosuppression caused by experimental cancers of the…

medRxiv · 2020 · Ayasoufi, K.; Pfaller, C. K.; Evgin, L.; Khadka, R. H.; Tritz, Z. P.; Goddery, E. N.; Fain, C. E.; Yokanovich, L. T.; Himes, B. T.; Jin, F.; Zheng, J.; Schuelke, M. R.; Hansen, M. J.; Tung, W.; Pease, L. R.; Vile, R. G.; Johnson, A. J.

Key facts

Title Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators
First author Ayasoufi, K.; Pfaller, C. K.; Evgin, L.; Khadka, R. H.; Tritz, Z. P.; Goddery, E. N.; Fain, C. E.; Yokanovich, L. T.; Himes, B. T.; Jin, F.; Zheng, J.; Schuelke, M. R.; Hansen, M. J.; Tung, W.; Pease, L. R.; Vile, R. G.; Johnson, A. J.
Journal medRxiv
Published Mar 25, 2020
DOI 10.1101/2020.03.24.006825
Devices mentioned BK110039, DEN000008, K022086, K022269, K032420, K051701, K103302, K132580, K181652, K183183, K191373, K201143 and 8 more
Product codes mentioned FTL, FTM, FZP, GAM, GAQ, GCJ, NDS, NPK, PCA, JCI, JJH, KIP and 5 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature